search
Back to results

Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy (EA&DPN)

Primary Purpose

Electroacupuncture, Acupuncture, Diabetic Polyneuropathy

Status
Recruiting
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Electroacupuncture
Sham Acupuncture
Sponsored by
Instituto Mexicano del Seguro Social
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Electroacupuncture focused on measuring Electroacupuncture, Acupuncture, Diabetic Polyneuropathy, Diabetic Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain, Nerve Conduction, Diabetic Pain

Eligibility Criteria

40 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with type 2 diabetes, with clinical and electrophysiologic diabetic peripheral polyneuropathy, neuropathic pain.

Exclusion Criteria:

  • Patients with systemic autoimmune diseases, hematological disorders, HIV, cancer history, pregnancy, intervention with acupuncture six months before.

Sites / Locations

  • Medical research unit in biochemistry, UMAE "Dr. Bernardo Sepúlveda".Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social.Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Sham Comparator

Experimental

Arm Label

Sham group

Interventional group

Arm Description

Sham acupuncture will be administered in a total of 32 sessions within five months.

Electroacupuncture will be administered in a total of 32 sessions within five months.

Outcomes

Primary Outcome Measures

Nerve Conduction Velocity
Measured by Nerve Conduction Velocity Study using the VIKING LIFE-SAVING EQUIPMENT, to determine Motor and Sensitive Nerve Conduction Velocity of common peroneal nerve, sural nerve, and tibial nerve. Sensitive Nerve Conduction (SCV). Distance between the receiving point and the stimulus point. SCV normal values: Peroneal nerve ≥ 41 m/s, tibial nerve ≥ 44 m/s, sural nerve ≥ 50 m/s. Motor Conduction Velocity (MCV). Distance between two points and the difference in incubation between them after superstimulation of the corresponding nerve branch. MCV normal values: Peroneal nerve ≥ 41 m/s, tibial nerve ≥ 44 m/s, sural nerve ≥ 60 m/s. *Values below those stipulated above indicate that NCV has slowed down, and is abnomal. The investigators expect a diminishment of SCV and MCV in sham acupuncture group from the first cycle of intervention whereas electroacupuncture group remains unchanged or even increases SCV and MCV.

Secondary Outcome Measures

Michigan Neuropathy Screening Instrument (MNSI).
It will be assessed with a lower extremity examination by a health professional of both feet in search of deformities, dry skin, calluses, infections, fissures and ulcers. Complemented with measurement of vibratory sensation, ankle reflexes, and Semmes-Weinstein monofilament test. The investigators expect improvement in the physical aspect of the foot in the electroacupuncture group, while in the sham acupuncture group the complication progresses.
Michigan Diabetic Neuropathy Score (MDNS)
Composed of three items where the sensory compromise is evaluated with the perception of vibration, 10 gr. monofilament and pin prick, in addition to the muscular strength of the toes, and the bicipital, tricipital, quadriceps and achilles muscle reflexes. The investigators expect a diminishment of MDNS score and clinical improvement in the electroacupuncture group and progression of clinical manifestations in the sham group.
Douleur Neuropathique en 4 Questions (DN-4)
A screening tool for neuropathic pain consisting of 10 interview questions (DN4-interview) and physical tests. A score greater than 4 points suggests neuropathic pain. The investigators expect decreased scores in the electroacupuncture group and increased or persistent scores in the sham group.
Numerical Pain Rating Scale (NRS)
Patients are only asked to circle the number between 0 and 10, 0 and 20 or 0 and 100 that best matches the intensity of their pain currently and in the last 7 days, where zero usually represents "no pain", while the upper limit represents "the worst pain of their life". The investigators expect diminishment of rating scale in electroacupuncture group and an increase in sham acupuncture group.
Quality life (SF-36)
It will be measured by The Short Form-36 Health Survey (SF-36) a measure of health status that consists of eight scaled scores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health), which are the weighted sums of the questions in their section. The investigators expect quality life improvement in electroacupuncture group while in sham acupuncture group might worsen.
Oxidative Stress
Determined by quantifying the concentrations of the lipoperoxidation product Malondialdehyde (MDA). An increase of MDA is expected in the sham group, while in the electroacupuncture group it is expected to decrease.
Inflammatory response
Assessed by changes in serum concentrations of proinflammatory (IL-6, IL1β, TNF-α and IL-18) and anti-inflammatory (IL-10) cytokines determined by quantitative ELISA by flow cytometry. The investigators expect increase of anti-inflammatory cytokine and decrease of proinflammatory cytokines in the electroacupuncture group, while in the sham group this is inversely presented.
Genetic expression
mRNA expression of 5-HT1AR, Neurokinin 1, α-adrenoreceptors, NGF (Nerve growth factor), CX3CR1, GAP-43 (Growth associated protein 43) and Neurotrophin (NT3), (Chemoline receptor 1) genes quantified by real-time PCR. The investigators expect an increase in gene expression in patients with electroacupuncture while in sham patients it is decreased or even unchanged.

Full Information

First Posted
August 22, 2022
Last Updated
September 27, 2023
Sponsor
Instituto Mexicano del Seguro Social
Collaborators
National Polytechnic Institute, Mexico, Instituto Nacional de Salud Publica, Mexico, Escuela Superior de Medicina, Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Universidad Nacional Autonoma de Mexico, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de Mexico, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de Mexico, Facultad de Medicina, UNAM
search

1. Study Identification

Unique Protocol Identification Number
NCT05521737
Brief Title
Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy
Acronym
EA&DPN
Official Title
Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy and Its Correlation With Nerve Conduction Changes
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2021 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
December 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Mexicano del Seguro Social
Collaborators
National Polytechnic Institute, Mexico, Instituto Nacional de Salud Publica, Mexico, Escuela Superior de Medicina, Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Universidad Nacional Autonoma de Mexico, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de Mexico, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de Mexico, Facultad de Medicina, UNAM

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a controlled clinical trial with the aim to study the effects of electroacupuncture on neuropathic pain reduction, quality of life and changes in sensory and motor nerve conduction velocity in patients with type 2 diabetes mellitus, beneficiaries of the familiar medical centers 20, 40 and 41 of the Instituto Mexicano del Seguro Social, at north of Mexico City, in colaboration with the human acupuncture specialty of the Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico.
Detailed Description
Controlled clinical trial to evaluate the effect of electroacupuncture on the reduction of neuropathic pain, quality of life; electrophysiological, inflammatory response, oxidative stress, and genetic expression, in patients with type 2 diabetes mellitus, beneficiaries from the family medical centers 20 , 40 and 41 of the Instituto Mexicano del Seguro Social, at north of Mexico City. Once the acceptance letter has been signed, a series of questionnaires (MNSI, MDNS, DN-4, NRS, and SF-36), and a physical examination will be carried out to meet the necessary criteria to continue participating. Only candidates with clinical diagnosis of diabetic polyneuropathy will have an electrophysiological examination by nerve conduction velocity study, if so, patients will be randomized to the electroacupunture or sham acupuncture groups. Before intervention, laboratory studies will be taken after fasting for 8 to 10 hours, to determine biochemichal profile (glucose, urea, creatinine, uric acid , triglycerides, total cholesterol, HDL and LDL), oxidative stress (Malondialdehyde), inflammatory response (IL-6, IL1β, TNF-α, IL-10 and IL-18 cytokines), and gene expression (5-HT1AR, Neurokinin 1, α-adrenoreceptors, NGF, CX3CR1, GAP-43, and NT3). Intervention will be applied in a total of 32 acupuncture sessions, divided into two intervention cycles, that is, 16 sessions over two months, with a rest period of one month in between. At the end of both cycles of interventions, the questionnaires, the nerve conduction velocity study the biochemical and molecular studies will be re-assessed. Finally, this will be re-evaluated after three months post-intervention in order to evaluate the effect of intervention over time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Electroacupuncture, Acupuncture, Diabetic Polyneuropathy, Diabetic Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain, Nerve Conduction
Keywords
Electroacupuncture, Acupuncture, Diabetic Polyneuropathy, Diabetic Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain, Nerve Conduction, Diabetic Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The protocol consists of two study groups, including a control group of sham acupuncture, and an interventional group of Electroacupuncture. Both interventions will be applied in a total of 32 sessions, divided into two intervention cycles, that is, 16 sessions over two months, with a rest period of one month in between. ,Acupuncture points are Zusanli (E36), Fenlong (E40), Yinlingquan (B9), Sanyinjiao (B6), Taichong (H3) and Zulinqi (VB41).
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Patient masking: During the application of the intervention, a bandage is placed over the patients eyes so that the participants cannot see the type of therapy applied (electroacupuncture or sham acupuncture). Statistical masking: The researcher in charge of the statistical analysis is unaware of the type of intervention received by the patients and delivers the results to the responsible researcher.
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sham group
Arm Type
Sham Comparator
Arm Description
Sham acupuncture will be administered in a total of 32 sessions within five months.
Arm Title
Interventional group
Arm Type
Experimental
Arm Description
Electroacupuncture will be administered in a total of 32 sessions within five months.
Intervention Type
Procedure
Intervention Name(s)
Electroacupuncture
Other Intervention Name(s)
EA
Intervention Description
Intervention consists of a total of 32 sessions, divided into two intervention cycles, that is, 16 sessions over two months, with a rest period of one month in between. EA is applied for 20 minutes at an alternating frequency of 2 Hz. Acupunctural points are Zusanli (E36), Fenlong (E40), Yinlingquan (B9), Sanyinjiao (B6), Taichong (H3) and Zulinqi (VB41).
Intervention Type
Procedure
Intervention Name(s)
Sham Acupuncture
Other Intervention Name(s)
Sham
Intervention Description
Intervention consists of a total of 32 sessions, divided into two intervention cycles, that is, 16 sessions over two months, with a rest period of one month in between. Sham acupuncture will be applied using a nonpuncture device without electrical stimulation at the same acupunctural points as in the EA group.
Primary Outcome Measure Information:
Title
Nerve Conduction Velocity
Description
Measured by Nerve Conduction Velocity Study using the VIKING LIFE-SAVING EQUIPMENT, to determine Motor and Sensitive Nerve Conduction Velocity of common peroneal nerve, sural nerve, and tibial nerve. Sensitive Nerve Conduction (SCV). Distance between the receiving point and the stimulus point. SCV normal values: Peroneal nerve ≥ 41 m/s, tibial nerve ≥ 44 m/s, sural nerve ≥ 50 m/s. Motor Conduction Velocity (MCV). Distance between two points and the difference in incubation between them after superstimulation of the corresponding nerve branch. MCV normal values: Peroneal nerve ≥ 41 m/s, tibial nerve ≥ 44 m/s, sural nerve ≥ 60 m/s. *Values below those stipulated above indicate that NCV has slowed down, and is abnomal. The investigators expect a diminishment of SCV and MCV in sham acupuncture group from the first cycle of intervention whereas electroacupuncture group remains unchanged or even increases SCV and MCV.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Secondary Outcome Measure Information:
Title
Michigan Neuropathy Screening Instrument (MNSI).
Description
It will be assessed with a lower extremity examination by a health professional of both feet in search of deformities, dry skin, calluses, infections, fissures and ulcers. Complemented with measurement of vibratory sensation, ankle reflexes, and Semmes-Weinstein monofilament test. The investigators expect improvement in the physical aspect of the foot in the electroacupuncture group, while in the sham acupuncture group the complication progresses.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Michigan Diabetic Neuropathy Score (MDNS)
Description
Composed of three items where the sensory compromise is evaluated with the perception of vibration, 10 gr. monofilament and pin prick, in addition to the muscular strength of the toes, and the bicipital, tricipital, quadriceps and achilles muscle reflexes. The investigators expect a diminishment of MDNS score and clinical improvement in the electroacupuncture group and progression of clinical manifestations in the sham group.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Douleur Neuropathique en 4 Questions (DN-4)
Description
A screening tool for neuropathic pain consisting of 10 interview questions (DN4-interview) and physical tests. A score greater than 4 points suggests neuropathic pain. The investigators expect decreased scores in the electroacupuncture group and increased or persistent scores in the sham group.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Numerical Pain Rating Scale (NRS)
Description
Patients are only asked to circle the number between 0 and 10, 0 and 20 or 0 and 100 that best matches the intensity of their pain currently and in the last 7 days, where zero usually represents "no pain", while the upper limit represents "the worst pain of their life". The investigators expect diminishment of rating scale in electroacupuncture group and an increase in sham acupuncture group.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Quality life (SF-36)
Description
It will be measured by The Short Form-36 Health Survey (SF-36) a measure of health status that consists of eight scaled scores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health), which are the weighted sums of the questions in their section. The investigators expect quality life improvement in electroacupuncture group while in sham acupuncture group might worsen.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Oxidative Stress
Description
Determined by quantifying the concentrations of the lipoperoxidation product Malondialdehyde (MDA). An increase of MDA is expected in the sham group, while in the electroacupuncture group it is expected to decrease.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Inflammatory response
Description
Assessed by changes in serum concentrations of proinflammatory (IL-6, IL1β, TNF-α and IL-18) and anti-inflammatory (IL-10) cytokines determined by quantitative ELISA by flow cytometry. The investigators expect increase of anti-inflammatory cytokine and decrease of proinflammatory cytokines in the electroacupuncture group, while in the sham group this is inversely presented.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.
Title
Genetic expression
Description
mRNA expression of 5-HT1AR, Neurokinin 1, α-adrenoreceptors, NGF (Nerve growth factor), CX3CR1, GAP-43 (Growth associated protein 43) and Neurotrophin (NT3), (Chemoline receptor 1) genes quantified by real-time PCR. The investigators expect an increase in gene expression in patients with electroacupuncture while in sham patients it is decreased or even unchanged.
Time Frame
Baseline evaluation, after the first and second cycle of intervention, respectively, and three months after the end of the intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with type 2 diabetes. Patients with clinical diabetic peripheral polyneuropathy. Patients with electrophysiological diagnosis of diabetic peripheral polyneuropathy in its different types of classification. Exclusion Criteria: Type 1 Diabetes or gestational diabetes. Systemic autoimmune diseases. Hematological disorders. HIV diagnosis. Cancer in treatment. Pregnancy. Other types of neurological disorders or neuropathies. Intervention with acupuncture six months previously. Patients with pacemarkers.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
José de Jesús Peralta Romero, PhD
Phone
5532318563
Email
drjjperalta@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
María Fernanda Pérez Hernández, MD
Phone
5574021093
Email
marferperezh@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
José de Jesús Peralta Romero, PhD
Organizational Affiliation
Instituto Mexicano del Seguro Social
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical research unit in biochemistry, UMAE "Dr. Bernardo Sepúlveda".Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social.
City
Mexico City
State/Province
Cuauhtémoc
ZIP/Postal Code
06720
Country
Mexico
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
José de Jesús Peralta Romero, PhD
Phone
5532318563
Email
drjjperalta@gmail.com
First Name & Middle Initial & Last Name & Degree
María Fernanda Pérez Hernández, MD
Phone
5574021093
Email
marferperezh@gmail.com
First Name & Middle Initial & Last Name & Degree
Sergio de Jesús Aguilar Castillo, MD
First Name & Middle Initial & Last Name & Degree
Alejandra Calderón Vallejo, MD
First Name & Middle Initial & Last Name & Degree
Cuauhtémoc Daniel Gómez Jiménez, MsC
First Name & Middle Initial & Last Name & Degree
Eduardo Rodríguez Guerrero, MsC
First Name & Middle Initial & Last Name & Degree
Macedonia Guadalupe Moreno Tovar, MD
First Name & Middle Initial & Last Name & Degree
Fátima Aguilar Morales, MD
First Name & Middle Initial & Last Name & Degree
María Esther Ocharan Hernández, PhD
First Name & Middle Initial & Last Name & Degree
Germán Velázquez García, MsC
First Name & Middle Initial & Last Name & Degree
Citlaltépetl Salinas Lara, PhD
First Name & Middle Initial & Last Name & Degree
Claudia Camelia Calzada Mendoza, PhD
First Name & Middle Initial & Last Name & Degree
Miguel Cruz López, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Available IPD and Supporting Information:
Available IPD/Information Type
Protocol reapproval report
Available IPD/Information URL
https://drive.google.com/file/d/1P3sbgleW3murWJq_FIaerBlFU12aga9z/view?usp=sharing

Learn more about this trial

Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy

We'll reach out to this number within 24 hrs